Visara licenses nerve growth factor therapy for rare eye disease Oct 13, 2026 07:02AM
NovaBridge to present givastomig trial data at ESMO 2026 Oct 8, 2026 04:06PM
H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) Aug 21, 2026 06:58AM
NovaBridge Biosciences names new CEO, replacing Xi-Yong Fu Jun 29, 2026 07:02AM
H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) Apr 8, 2026 07:14AM


Mar 16, 2026 11:40AM H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) following FDA meeting feedback
Feb 6, 2026 06:44AM NovaBridge Biosciences (NBP) PT Raised to $9 at H.C. Wainwright
Jan 20, 2026 07:05AM NovaBridge chairman plans to buy up to $5 million in company shares
Jan 6, 2026 01:42PM Brookline on NovaBridge Biosciences (NBP) Amid 10 Drop: 'Givastomig Dose Expansion Data Promising, Compares Favorably to Competition'
Oct 29, 2025 09:01AM I-MAB rebrands as NovaBridge Biosciences, ticker changes to NBP